State Of Michigan Retirement System Ligand Pharmaceuticals Inc Transaction History

State Of Michigan Retirement System

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Oct 27, 2021	SELL	$102.33 - $144.73 $431,832 - $610,760	-4,220 Closed	0 $0
Q2 2021 Jul 27, 2021	SELL	$113.03 - $155.64 $214,757 - $295,716	-1,900 Reduced 31.05%	4,220 $554,000
Q1 2021 May 03, 2021	BUY	$99.52 - $215.83 $29,856 - $64,749	300 Added 5.15%	6,120 $933,000
Q2 2020 Jul 29, 2020	BUY	$68.28 - $123.65 $83,301 - $150,853	1,220 Added 26.52%	5,820 $651,000
Q1 2020 May 01, 2020	BUY	$63.37 - $107.88 $270,273 - $460,108	4,265 Added 1273.13%	4,600 $335,000
Q1 2020 Apr 28, 2020	SELL	$63.37 - $107.88 $308,295 - $524,836	-4,865 Reduced 93.56%	335 $24,000
Q4 2019 Jan 24, 2020	SELL	$96.94 - $113.59 $29,082 - $34,077	-300 Reduced 5.45%	5,200 $542,000
Q3 2019 Oct 22, 2019	SELL	$86.25 - $120.16 $25,875 - $36,048	-300 Reduced 5.17%	5,500 $547,000
Q2 2019 Jul 26, 2019	SELL	$107.38 - $129.34 $161,070 - $194,010	-1,500 Reduced 20.55%	5,800 $662,000
Q1 2019 May 06, 2019	SELL	$105.93 - $142.47 $31,779 - $42,741	-300 Reduced 3.95%	7,300 $918,000
Q4 2018 Feb 01, 2019	BUY	$128.36 - $272.13 $975,536 - $2.07 Million	7,600 New	7,600 $1.03 Million

257

18.2M

26.8K

9.3K

Ticker LGND
Exchange OTC
Sector Healthcare
Industry Biotechnology
Shares Outstandng 16,882,800
Market Cap $1.88B
Description
Ligand Pharmaceuticals Incorporated, a biopharmaceutical company, focuses on developing or acquiring technologies that help pharmaceutical companies to discover and develop medicines worldwide. Its commercial programs include Kyprolis and Evomela, which are used to treat multiple myeloma; Veklury for the treatment of moderate or severe COVID-19;...

Get notified when there are updates to the investment portfolio of State Of Michigan Retirement System, based on Form 13F filings with the SEC.

Stay updated on State Of Michigan Retirement System with notifications on news.